IGS GeboJagema supports Project TryMe

IGS GeboJagema supports Project TryMe, the foundation trying to accelerate the search for treatments for ALS, the devastating neurological muscle disease.

ALS patients do not have time to lose. Many patients want to participate in research into new medicines, but at present, only 2% of ALS patients can participate, caused by the limited budgets. Project TryMe enables 25% of ALS patients to participate in drug research projects.

Project TryMe
Such large-scale genetic research into the origins of ALS is unprecedented! As such, we are fully committed to making a revolutionary breakthrough in the search for the cause of ALS. But, to reach our goals, we need your help. More than 200,000 people worldwide are living with Amyotrophic Lateral Sclerosis (ALS), otherwise known as Motor Neuron Disease (MND) or Lou Gehrig’s disease. Relatively little is known about the cause of this progressively degenerative neurological disease. There is still no treatment. The average life expectancy of ALS patients is three years.

It is almost certain that the disease has a genetic basis. Project TryMe is a large-scale research initiative devoted to discovering the genetic cause of ALS. The ultimate goal is to identify genes that are associated with ALS. The function of these genes may lead to disease pathways for which treatment can be developed.

Help us to start as much drug research as possible! Your donation is highly appreciated.

Bank account: IBAN NL 89 INGB 0007 6384 29 – BIC Code: INGBNL2A to ‘IGS beats ALS’.

 

 

Help us to start as much drug research as possible!

Please donate

Contact us